Flow cytometric characterization and clinical outcome of CD4+ T-cell lymphoma in dogs: 67 cases. [PDF]
, 2014 BackgroundCanine T-cell lymphoma (TCL) is conventionally considered an aggressive disease, but some forms are histologically and clinically indolent. CD4 TCL is reported to be the most common subtype of TCL.
Avery, AC +8 more
core +2 more sources
Haematologica, 2017 In addition to angioimmunoblastic T-cell lymphoma (AITL), the 2016 revised WHO classification of haematological malignancies recognizes two provisional lymphoma entities of follicular helper T-cell (TFH) derivation, namely follicular peripheral T-cell ...
M. P. Dobay +20 more
semanticscholar +1 more source
Annals of Oncology, 1991 The development of T cells from stem (progenitor) cells to effector cells results from a two-wave process of proliferation and differentiation. The cells of the first differentiation wave are the precursor T cells, and those of the second differentiation wave are peripheral T cells.
Michael Kruschwitz +3 more
openaire +3 more sources
Anaplastic, T-cell, Non-Hodgkin's Lymphoma Presenting with Haematuria [PDF]
, 2008 Non-Hodgkin's lymphoma (NHL) represents about 3% of new cancer cases[1]. Bladder involvement has been found in approximately 3-13% of NHL patients when studied at postmortem[2].
Abdelhadi, S +3 more
core +3 more sources
Oncogenic fusion protein BCR-FGFR1 requires the breakpoint cluster region-mediated oligomerization and chaperonin Hsp90 for activation. [PDF]
, 2020 Mutation and translocation of fibroblast growth factor receptors often lead to aberrant signaling and cancer. This work focuses on the t(8;22)(p11;q11) chromosomal translocation which creates the breakpoint cluster region (BCR) fibroblast growth factor ...
Bisom-Rapp, Ezra W +4 more
core +2 more sources
Hematopoietic stem cell transplantation in B- and T-cell lymphoma [PDF]
, 2013 Huijgens, P.C. [Promotor]Mulder, C.J.J. [Promotor]Dongen, G.A.M.S.
Visser, O.
core +8 more sources
An Update in Management of Noncutaneous T-Cell Lymphomas
Advances in Hematology, 2010 T-cell lymphoma is a heterogeneous group of diseases. Except for ALK positive anaplastic large cell lymphoma, T-cell lymphoma responds to conventional chemotherapy unfavourably, and most patients carry poor prognosis.
Y. Y. Hwang, R. H. S. Liang
doaj +1 more source
Contribution of immunocytochemistry to the diagnosis of usual and unusual lymphoma cases
Journal of Cytology, 2018 Some of the limitations of fine needle aspiration (FNA) in the cytodiagnosis of lymphoma include problems encountered in differentiating reactive hyperplasia from low-grade non-Hodgkin lymphoma (NHL), lower cytodiagnostic accuracy for NHL with a ...
Dilip K Das
doaj +1 more source
Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma.
Blood, 2017 Mature T-cell lymphomas, including peripheral T-cell lymphoma (PTCL) and extranodal NK/T-cell lymphoma (NKTL), represent a heterogeneous group of non-Hodgkin lymphomas with dismal outcomes and limited treatment options.
T. Song +28 more
semanticscholar +1 more source
Origin and pathogenesis of nodular lymphocyte–predominant Hodgkin lymphoma as revealed by global gene expression analysis [PDF]
, 2008 The pathogenesis of nodular lymphocyte–predominant Hodgkin lymphoma (NLPHL) and its relationship to other lymphomas are largely unknown. This is partly because of the technical challenge of analyzing its rare neoplastic lymphocytic and histiocytic (L&H ...
Brune, Verena +12 more
core +1 more source